{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T21:33:44Z","timestamp":1793568824571,"version":"4.5.0"},"reference-count":57,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2015,9]]},"DOI":"10.1097\/bor.0000000000000202","type":"journal-article","created":{"date-parts":[[2015,6,27]],"date-time":"2015-06-27T17:31:44Z","timestamp":1435426304000},"page":"454-460","source":"Crossref","is-referenced-by-count":89,"title":["Malignancies in systemic lupus erythematosus"],"prefix":"10.1097","volume":"27","author":[{"given":"Gillian C.","family":"Goobie","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sasha","family":"Bernatsky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosalind","family":"Ramsey-Goldman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ann E.","family":"Clarke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-6-20210128","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.jaut.2012.12.009","article-title":"Cancer risk in systemic lupus: an updated international multicentre cohort study.","volume":"42","author":"Bernatsky","year":"2013","journal-title":"J Autoimmun"},{"key":"R2-6-20210128","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1016\/j.amjmed.2010.08.006","article-title":"Malignancy in systemic lupus erythematosus: a nation-wide cohort study in Taiwan.","volume":"123","author":"Chen","year":"2010","journal-title":"Am J of Medicine"},{"key":"R3-6-20210128","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1177\/0961203313497118","article-title":"Cancer complicating systemic lupus erythematosus: a dichotomy emerging from a nested case-control study.","volume":"22","author":"Dey","year":"2013","journal-title":"Lupus"},{"key":"R4-6-20210128","doi-asserted-by":"crossref","first-page":"3032","DOI":"10.1002\/art.30483","article-title":"High incidence of potentially virus-induced malignancies in systemic lupus erythematosus: a long-term follow-up study in a Danish cohort.","volume":"63","author":"Dreyer","year":"2011","journal-title":"Arthritis Rheum"},{"key":"R5-6-20210128","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1177\/0961203313520060","article-title":"Lung, liver, prostate, bladder malignancies risk in systemic lupus erythematosus: a meta-analysis.","volume":"23","author":"Ni","year":"2015","journal-title":"Lupus"},{"key":"R6-6-20210128","doi-asserted-by":"crossref","first-page":"2503","DOI":"10.1002\/art.38731","article-title":"Mortality associated with systemic lupus erythematosus in France assessed by multiple-cause-of-death analysis.","volume":"66","author":"Thomas","year":"2014","journal-title":"Arthritis Rheum"},{"key":"R7-6-20210128","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1002\/acr.22173","article-title":"Overall and cause-specific mortality in patients with systemic lupus erythematosus: a meta-analysis of observational studies.","volume":"66","author":"Yurkovich","year":"2014","journal-title":"Arthritis Care Res"},{"key":"R8-6-20210128","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1159\/000350165","article-title":"Nonlymphoma hematologic malignancies in systemic lupus erythematosus.","volume":"85","author":"Lu","year":"2013","journal-title":"Oncology"},{"key":"R9-6-20210128","doi-asserted-by":"crossref","first-page":"2025","DOI":"10.1093\/annonc\/mdu365","article-title":"Autoimmune diseases associated with non-Hodgkin lymphoma: a nationwide cohort study.","volume":"25","author":"Fallah","year":"2014","journal-title":"Ann Oncol"},{"key":"R10-6-20210128","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1016\/j.leukres.2014.06.025","article-title":"Systemic lupus erythematosus is associated with increased incidence of hematologic malignancies: a meta-analysis of prospective cohort studies.","volume":"38","author":"Apor","year":"2014","journal-title":"Leuk Res"},{"key":"R11-6-20210128","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1136\/annrheumdis-2012-202099","article-title":"Lymphoma risk in systemic lupus: effects of disease activity versus treatment.","volume":"73","author":"Bernatsky","year":"2014","journal-title":"Ann Rheum Dis"},{"key":"R12-6-20210128","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2013\/535738","article-title":"Epstein-Barr virus in systemic autoimmune diseases.","volume":"2013","author":"Draborg","year":"2013","journal-title":"Clin Dev Immunol"},{"key":"R13-6-20210128","doi-asserted-by":"crossref","first-page":"143","DOI":"10.3109\/03009742.2014.973061","article-title":"Antibodies to early EBV, CMV, and HHV6 antigens in systemic lupus patients.","volume":"44","author":"Rasmussen","year":"2014","journal-title":"Scand J Rheumatol"},{"key":"R14-6-20210128","doi-asserted-by":"crossref","first-page":"R3","DOI":"10.1186\/ar4429","article-title":"Systematic review and meta-analysis of the sero-epidemiological association between Epstein-Barr virus and systemic lupus erythematosus.","volume":"16","author":"Hanlon","year":"2014","journal-title":"Arthritis Res Ther"},{"key":"R15-6-20210128","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1200\/JCO.2013.51.5304","article-title":"Sustained complete responses in patients with lymphoma receiving autologous cytotoxic T lymphocytes targeting Epstein-Barr virus latent membrane proteins.","volume":"32","author":"Bollard","year":"2014","journal-title":"J Clin Onc"},{"key":"R16-6-20210128","doi-asserted-by":"crossref","first-page":"74","DOI":"10.3390\/vaccines3010074","article-title":"EBV-associated cancer and autoimmunity: searching for therapies.","volume":"3","author":"Capone","year":"2015","journal-title":"Vaccines"},{"key":"R17-6-20210128","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.pharmthera.2013.09.004","article-title":"Targeting interleukin-6 in inflammatory autoimmune diseases and cancers.","volume":"141","author":"Yao","year":"2014","journal-title":"Pharmacol Therap"},{"key":"R18-6-20210128","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1042\/bj20030407","article-title":"Principles of interleukin (IL)-6-type cytokine signalling and its regulation.","volume":"374","author":"Heinrich","year":"2003","journal-title":"Biochem J"},{"key":"R19-6-20210128","doi-asserted-by":"crossref","first-page":"3783","DOI":"10.1182\/blood-2012-04-424630","article-title":"Role of the microenvironment in mantle cell lymphoma: IL-6 is an important survival factor for the tumor cells.","volume":"120","author":"Zhang","year":"2012","journal-title":"Blood"},{"key":"R20-6-20210128","doi-asserted-by":"crossref","first-page":"2521","DOI":"10.1002\/art.38716","article-title":"Interleukin-6 deficiency corrects nephritis, lymphocyte abnormalities, and secondary Sjogrens syndrome features in lupus-prone Sle1.Yaa Mice.","volume":"66","author":"Miaer-Moore","year":"2014","journal-title":"Arthritis Rheumatol"},{"key":"R21-6-20210128","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1136\/annrheumdis-2012-201310","article-title":"Impact of antiinterleukin-6 receptor blockade on circulating T and B cell subsets in patients with systemic lupus erythematosus.","volume":"72","author":"Shirota","year":"2013","journal-title":"Ann Rheum Dis"},{"key":"R22-6-20210128","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1038\/nrrheum.2014.33","article-title":"The BAFFAPRIL system in SLE pathogenesis.","volume":"10","author":"Vincent","year":"2014","journal-title":"Nat Rev Rheumatol"},{"key":"R23-6-20210128","doi-asserted-by":"crossref","first-page":"A74","DOI":"10.1136\/annrheumdis-2015-207259.170","article-title":"Only BAFF mRNA, not BAFF protein level in blood, is associated with SLE activity over one year.","volume":"74","author":"Zollars","year":"2015","journal-title":"Ann Rheum Dis"},{"key":"R24-6-20210128","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1016\/S0140-6736(10)61354-2","article-title":"Efficacy and safety of belimumab in patients with active systemic lupus erythematosus: a randomised, placebo-controlled, phase 3 trial.","volume":"377","author":"Navarra","year":"2011","journal-title":"Lancet"},{"key":"R25-6-20210128","doi-asserted-by":"crossref","first-page":"3918","DOI":"10.1002\/art.30613","article-title":"A phase III, randomized, placebo-controlled study of belimumab, a monoclonal antibody that inhibits B lymphocyte stimulator, in patients with systemic lupus erythematosus.","volume":"63","author":"Furie","year":"2011","journal-title":"Arthritis Rheum"},{"key":"R26-6-20210128","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/j.bcp.2012.05.019","article-title":"The therapeutic effects of rGelBLyS fusion toxin in in vitro and in vivo models of mantle cell lymphoma.","volume":"84","author":"Lyu","year":"2012","journal-title":"Biochem Parmacol"},{"key":"R27-6-20210128","doi-asserted-by":"crossref","first-page":"1891","DOI":"10.3899\/jrheum.101190","article-title":"Expression of APRIL in diffuse large B cell lymphomas from patients with systemic lupus erythematosus and rheumatoid arthritis.","volume":"38","author":"Lofstrom","year":"2011","journal-title":"J Rheumatol"},{"key":"R28-6-20210128","doi-asserted-by":"crossref","first-page":"542","DOI":"10.4049\/jimmunol.1402070","article-title":"The immunoregulator soluble TACI is released by ADAM10 and reflects B cell activation in autoimmunity.","volume":"194","author":"Hoffman","year":"2015","journal-title":"J Immunol"},{"key":"R29-6-20210128","doi-asserted-by":"crossref","first-page":"3960","DOI":"10.1182\/blood-2013-04-497693","article-title":"Chronic lymphocytic leukemia disease progression is accelerated by APRIL-TACI interaction in the TCL1 transgenic mouse model.","volume":"122","author":"Lascano","year":"2013","journal-title":"Blood"},{"key":"R31-6-20210128","first-page":"1","article-title":"Efficacy and safety of atacicept for prevention of flares in patients with moderate-to-severe systemic lupus erythematosus (SLE): 52-week data (APRIL-SLE randomised trial).","volume":"0","author":"Isenberg","year":"2014","journal-title":"Ann Rheum Dis"},{"key":"R32-6-20210128","doi-asserted-by":"crossref","first-page":"6856","DOI":"10.1182\/blood-2011-01-330852","article-title":"Development and characterization of APRIL antagonistic monoclonal antibodies for treatment of B-cell lymphomas.","volume":"117","author":"Guadagnoli","year":"2011","journal-title":"Blood"},{"key":"R33-6-20210128","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1183\/09031936.00222911","article-title":"Effect of autoimmune diseases on risk and survival in histology-specific lung cancer.","volume":"40","author":"Hemminki","year":"2012","journal-title":"Eur Resp J"},{"key":"R34-6-20210128","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1007\/s10067-013-2224-4","article-title":"Smoking and the risk of systemic lupus erythematosus.","volume":"32","author":"Ekblom-Kullberg","year":"2013","journal-title":"Clin Rheumatol"},{"key":"R35-6-20210128","doi-asserted-by":"crossref","first-page":"2283","DOI":"10.3892\/ol.2015.3019","article-title":"Antiproliferative action of IL-6R-targeted antibody tocilizumab for nonsmall cell lung cancer cells.","volume":"9","author":"Kim","year":"2015","journal-title":"Oncol Lett"},{"key":"R36-6-20210128","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1158\/1078-0432.CCR-14-2291","article-title":"Interleukin-6 as a therapeutic target.","volume":"21","author":"Rossi","year":"2015","journal-title":"Clin Cancer Res"},{"key":"R37-6-20210128","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1016\/j.cgh.2013.11.007","article-title":"Increased risk of hepatobiliary cancers after hospitalization for autoimmune disease.","volume":"12","author":"Castro","year":"2014","journal-title":"Clin Gastroenterol Hepatol"},{"key":"R38-6-20210128","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1097\/00000441-200605000-00003","article-title":"Prevalence of active hepatitis C virus infection in patients with systemic lupus erythematosus.","volume":"331","author":"Ahmed","year":"2006","journal-title":"Am J Med Sci"},{"key":"R39-6-20210128","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.1038\/bjc.2011.115","article-title":"Breast, ovarian, and endometrial malignancies in systemic lupus erythematosus: a meta-analysis.","volume":"104","author":"Bernatsky","year":"2011","journal-title":"Br J Cancer"},{"key":"R40-6-20210128","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1126\/scitranslmed.3004385","article-title":"Targeting cancer with a lupus autoantibody.","volume":"4","author":"Hansen","year":"2012","journal-title":"Sci Transl Med"},{"key":"R41-6-20210128","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1159\/000353138","article-title":"Breast cancer in systemic lupus erythematosus.","volume":"85","author":"Tessier-Cloutier","year":"2013","journal-title":"Oncology"},{"key":"R42-6-20210128","first-page":"1","article-title":"A nucleolytic lupus autoantibody is toxic to BRCA2-deficient cancer cells.","volume":"5","author":"Noble","year":"2014","journal-title":"Sci Rep"},{"key":"R43-6-20210128","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.imlet.2015.01.007","article-title":"Heat shock protein 27 and its regulatory molecules express differentially in SLE patients with distinct autoantibody profiles.","volume":"164","author":"Rai","year":"2015","journal-title":"Immunol Lett"},{"key":"R44-6-20210128","doi-asserted-by":"crossref","first-page":"527","DOI":"10.5603\/FHC.2012.0074","article-title":"Hsp27 expression in invasive ductal breast carcinoma.","volume":"50","author":"Grzegrzolka","year":"2012","journal-title":"Folia Histo Cytobio"},{"key":"R45-6-20210128","doi-asserted-by":"crossref","first-page":"8699","DOI":"10.1073\/pnas.1017909109","article-title":"Suppression of heat shock protein 27 induces long-term dormancy in human breast cancer.","volume":"109","author":"Straume","year":"2012","journal-title":"Proc Natl Acad Sci USA"},{"key":"R46-6-20210128","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pone.0064378","article-title":"Proteomic profiling reveals that resveratrol inhibits HSP27 expression and sensitizes breast cancer cells to doxorubicin therapy.","volume":"8","author":"Diaz-Chavez","year":"2013","journal-title":"PLoS One"},{"key":"R47-6-20210128","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1016\/j.autrev.2014.03.001","article-title":"Increased risk of high grade cervical squamous cell intraepithelial lesions in systemic lupus erythematosus: a meta-analysis of the literature.","volume":"13","author":"Zard","year":"2014","journal-title":"Autoimmun Rev"},{"key":"R48-6-20210128","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1007\/s00296-012-2426-0","article-title":"Prevalence of cervical human papillomavirus infection in women with systemic lupus erythematosus.","volume":"33","author":"Lyrio","year":"2013","journal-title":"Rheumatol Int"},{"key":"R49-6-20210128","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1007\/s00432-014-1604-8","article-title":"A systematic review of the epidemiological literature on the risk of urological cancers in systemic lupus erythematosus.","volume":"140","author":"Huang","year":"2014","journal-title":"J Cancer Res Clin Oncol"},{"key":"R50-6-20210128","doi-asserted-by":"crossref","first-page":"2262","DOI":"10.1016\/j.juro.2012.12.014","article-title":"Autoimmune diseases and subsequent urological cancer.","volume":"189","author":"Liu","year":"2013","journal-title":"J Urol"},{"key":"R51-6-20210128","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1097\/MOU.0b013e32835e9f1a","article-title":"The promise of heat shock protein inhibitors in the treatment of castration resistant prostate cancer.","volume":"23","author":"Ischia","year":"2013","journal-title":"Curr Opin Urol"},{"key":"R52-6-20210128","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1038\/sj.bjc.6605227","article-title":"Hsp-27 expression at diagnosis predicts poor clinical outcome in prostate cancer independent of ETS-gene rearrangement.","volume":"101","author":"Foster","year":"2009","journal-title":"Br J Cancer"},{"key":"R53-6-20210128","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.eururo.2013.12.019","article-title":"Suppression of heat shock protein 27 using OGX-427 induces endoplasmic reticulum stress and potentiates heat shock protein 90 inhibitors to delay castrate-resistant prostate cancer.","volume":"66","author":"Lamoureux","year":"2014","journal-title":"Eur Urol"},{"key":"R54-6-20210128","first-page":"6270","article-title":"Thyroid cancer in systemic lupus erythematosus: a meta analysis.","volume":"7","author":"Zhang","year":"2014","journal-title":"Int J Clin Exp Pathol"},{"key":"R55-6-20210128","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1210\/jc.2009-0677","article-title":"Thyroid cancer in systemic lupus erythematosus: a case-control study.","volume":"95","author":"Antonelli","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"key":"R56-6-20210128","first-page":"1","article-title":"What investigations are needed to optimally monitor for malignancies in SLE L","volume":"0","author":"Tessier-Cloutier","year":"2015","journal-title":"upus"},{"key":"R57-6-20210128","doi-asserted-by":"crossref","first-page":"1","DOI":"10.14745\/ccdr.v38i00a01","article-title":"National Advisory Committee on Immunization (NACI) update on human papillomavirus (HPV) vaccines.","volume":"38","author":"Dawar","year":"2012","journal-title":"Canada Communicable Disease Report"},{"key":"R58-6-20210128","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1136\/annrheumdis-2012-201393","article-title":"Immunogenicity and safety of a quadrivalent human papillomavirus vaccine in patients with systemic lupus erythematosus: a case-control study.","volume":"72","author":"Mok","year":"2013","journal-title":"Ann Rheum Dis"}],"container-title":["Current Opinion in Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/BOR.0000000000000202","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,13]],"date-time":"2021-05-13T23:34:01Z","timestamp":1620948841000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00002281-201509000-00006"}},"subtitle":["a 2015 update"],"short-title":[],"issued":{"date-parts":[[2015,9]]},"references-count":57,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2015]]}},"URL":"https:\/\/doi.org\/10.1097\/bor.0000000000000202","relation":{},"ISSN":["1040-8711"],"issn-type":[{"value":"1040-8711","type":"print"}],"subject":[],"published":{"date-parts":[[2015,9]]}}}